Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Grant Overview
Application Deadline
November 10, 2026
Funding Organization or Agency
National Institutes of Health
Award or Funding Amount
Not specified
Apply for This Grant
Official Grant or Application Link
